People

Julia Tsai
Senior vice president of clinical development at Ovid Therapeutics, responsible for clinical strategy and medical affairs. Joined in 2020 after clinical development leadership at Marinus Pharmaceuticals, with experience in rare and general epilepsies. Holds a doctorate in physiology and biophysics from NYU and a psychology degree from Cornell.
Roles
Ovid Therapeutics
CurrentSenior Vice President of Clinical Development